Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Acquisitions & Divestments: 2017-2025

Historic Change in Acquisitions & Divestments for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to $27.3 million.

  • Puma Biotechnology's Change in Acquisitions & Divestments rose 67.14% to $27.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.1 million, marking a year-over-year increase of 41.29%. This contributed to the annual value of $55.8 million for FY2024, which is 222.30% up from last year.
  • Latest data reveals that Puma Biotechnology reported Change in Acquisitions & Divestments of $27.3 million as of Q3 2025, which was up 155.65% from $10.7 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Change in Acquisitions & Divestments high stood at $27.3 million for Q3 2025, and its period low was -$37,000 during Q4 2022.
  • For the 3-year period, Puma Biotechnology's Change in Acquisitions & Divestments averaged around $12.5 million, with its median value being $13.1 million (2023).
  • In the last 5 years, Puma Biotechnology's Change in Acquisitions & Divestments crashed by 100.80% in 2022 and then soared by 8,686.49% in 2023.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Change in Acquisitions & Divestments stood at $4.6 million in 2021, then crashed by 100.80% to -$37,000 in 2022, then spiked by 8,686.49% to $3.2 million in 2023, then skyrocketed by 308.25% to $13.0 million in 2024, then soared by 67.14% to $27.3 million in 2025.
  • Its Change in Acquisitions & Divestments was $27.3 million in Q3 2025, compared to $10.7 million in Q2 2025 and $14.1 million in Q1 2025.